✦ LIBER ✦

A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis

✍ Scribed by Ivan R Schwab; Mitchell Friedlaender; James McCulley; Steven J Lichtenstein; C.Thomas Moran

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of 0.5% levofloxacin

✍ S.J. Lichtenstein; M. Rinehart 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Efficacy and safety of 0.5% levofloxacin

✍ Steven J Lichtenstein; Mike Rinehart 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 393 KB

Clinical evaluation of ketorolac trometh

✍ Zuhair Ballas; Malcolm Blumenthal; David G. Tinkelman; Robert Kriz; Gary Rupp 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 798 KB

Comparative clinical study of norfloxaci

✍ Jose Luis Tovilla; Fernando Avila; Jaime Quintero; Renzo Rhenals 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 323 KB

Double-masked, paired-comparison clinica

✍ David G. Tinkelman; Gary Rupp; Herbert Kaufman; James Pugely; Nathan Schultz 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 747 KB

Ketorolac tromethamine 0.5% ophthalmic s

✍ Jeff Heier; Janet K Cheetham; Ronald DeGryse; Monte S Dirks; Delmar R Caldwell; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 207 KB